The Business Times
business-time-50

Vickers Venture SPAC to merge with subsidiary of Sorrento Therapeutics

google-preferred-sourceAdd BT as a preferred source
Michelle Zhu

Michelle Zhu

Published Fri, Mar 18, 2022 · 09:50 PM

    Singapore

    VICKERS Venture Partners' Nasdaq-listed special purpose acquisition company (SPAC) Vickers Vantage Corp I is merging with Scilex Holding Company, a commercial biopharmaceutical company focused on developing and commercialising non-opioid therapies for patients with acute and chronic pain.

    Scilex Holding is a subsidiary of pharma giant Sorrento Therapeutics, which is also listed on the Nasdaq.

    Vickers Venture PartnersSPACNasdaqHealthcare

    TRENDING NOW

    Tribunal Magistrate Jared Kang described dismissal law as “a little more layered, difficult and unclear than it perhaps needed to be”.

    Firm loses wrongful dismissal case despite following termination clause

    The Vietnamese economy has long relied heavily on bank lending, straining commercial banks as they shoulder the bulk of the financing needed by companies and large infrastructure projects.

    Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks

    UOB’s asset quality was a recurring theme across all broker notes.

    Citi, OCBC downgrade UOB post-Q2 results; RHB upgrades on valuation

    Soilbuild and its executive chairman Lim Chap Huat are reportedly seeking unspecified damages over Brookfield’s alleged breach of their agreement.

    Soilbuild’s Lim Chap Huat sues Brookfield, claims it reneged on joint venture: WSJ

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More